A multigenic program mediating breast cancer metastasis to bone
- PMID: 12842083
- DOI: 10.1016/s1535-6108(03)00132-6
A multigenic program mediating breast cancer metastasis to bone
Abstract
We investigated the molecular basis for osteolytic bone metastasis by selecting human breast cancer cell line subpopulations with elevated metastatic activity and functionally validating genes that are overexpressed in these cells. These genes act cooperatively to cause osteolytic metastasis, and most of them encode secreted and cell surface proteins. Two of these genes, interleukin-11 and CTGF, encode osteolytic and angiogenic factors whose expression is further increased by the prometastatic cytokine TGF beta. Overexpression of this bone metastasis gene set is superimposed on a poor-prognosis gene expression signature already present in the parental breast cancer population, suggesting that metastasis requires a set of functions beyond those underlying the emergence of the primary tumor.
Comment in
-
Metastatic cells will take any help they can get.Cancer Cell. 2011 Dec 13;20(6):689-90. doi: 10.1016/j.ccr.2011.11.022. Cancer Cell. 2011. PMID: 22172715 Free PMC article.
Similar articles
-
Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.J Bone Miner Res. 2006 Jul;21(7):1045-59. doi: 10.1359/jbmr.060416. J Bone Miner Res. 2006. PMID: 16813525
-
Identification of microRNAs inhibiting TGF-β-induced IL-11 production in bone metastatic breast cancer cells.PLoS One. 2012;7(5):e37361. doi: 10.1371/journal.pone.0037361. Epub 2012 May 21. PLoS One. 2012. PMID: 22629385 Free PMC article.
-
Bone metastasis from breast cancer involves elevated IL-11 expression and the gp130/STAT3 pathway.Med Oncol. 2013;30(3):634. doi: 10.1007/s12032-013-0634-4. Epub 2013 Jun 28. Med Oncol. 2013. PMID: 23813018
-
Parathyroid hormone-related protein and bone metastases.Cancer. 1997 Oct 15;80(8 Suppl):1572-80. doi: 10.1002/(sici)1097-0142(19971015)80:8+<1572::aid-cncr7>3.3.co;2-d. Cancer. 1997. PMID: 9362424 Review.
-
Transforming growth factor-beta in osteolytic breast cancer bone metastases.Clin Orthop Relat Res. 2003 Oct;(415 Suppl):S32-8. doi: 10.1097/01.blo.0000093055.96273.69. Clin Orthop Relat Res. 2003. PMID: 14600590 Review.
Cited by
-
Differential bone morphology and hypoxia activity in skeletal metastases of ER+ and ER- breast cancer.Commun Biol. 2024 Nov 21;7(1):1545. doi: 10.1038/s42003-024-07247-6. Commun Biol. 2024. PMID: 39572705 Free PMC article.
-
Dormancy-inducing 3D engineered matrix uncovers mechanosensitive and drug-protective FHL2-p21 signaling axis.Sci Adv. 2024 Nov 8;10(45):eadr3997. doi: 10.1126/sciadv.adr3997. Epub 2024 Nov 6. Sci Adv. 2024. PMID: 39504377 Free PMC article.
-
Delineating the nexus between gut-intratumoral microbiome and osteo-immune system in bone metastases.Bone Rep. 2024 Oct 10;23:101809. doi: 10.1016/j.bonr.2024.101809. eCollection 2024 Dec. Bone Rep. 2024. PMID: 39497943 Free PMC article. Review.
-
A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features.Nat Med. 2024 Nov;30(11):3236-3249. doi: 10.1038/s41591-024-03215-z. Epub 2024 Oct 30. Nat Med. 2024. PMID: 39478111 Free PMC article.
-
Insights into the metastatic bone marrow niche gained from fibronectin and β1 integrin transgenic mice.Neoplasia. 2024 Dec;58:101058. doi: 10.1016/j.neo.2024.101058. Epub 2024 Oct 15. Neoplasia. 2024. PMID: 39413671 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous